The price of SELLAS Life Sciences Group Inc (NASDAQ: SLS) closed at $1.07 in the last session, up 5.94% from day before closing price of $1.01. In other words, the price has increased by $+0.0600 from its previous closing price. On the day, 2493167 shares were traded.
Ratios:
We take a closer look at SLS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.44 and its Current Ratio is at 0.44.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on July 21, 2021, initiated with a Overweight rating and assigned the stock a target price of $18.
On April 02, 2018, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $11.H.C. Wainwright initiated its Buy rating on April 02, 2018, with a $11 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SLS now has a Market Capitalization of 59.01M and an Enterprise Value of 55.68M. Its current Enterprise Value per Revenue stands at 20.84 whereas that against EBITDA is -1.42.
Stock Price History:
Over the past 52 weeks, SLS has reached a high of $1.91, while it has fallen to a 52-week low of $0.50. The 50-Day Moving Average of the stock is 0.8504, while the 200-Day Moving Average is calculated to be 1.2129.
Shares Statistics:
According to the various share statistics, SLS traded on average about 1.33M shares per day over the past 3-months and 2.14M shares per day over the past 10 days. A total of 55.15M shares are outstanding, with a floating share count of 54.64M. Insiders hold about 0.92% of the company’s shares, while institutions hold 10.11% stake in the company. Shares short for SLS as of Feb 29, 2024 were 4.51M with a Short Ratio of 3.39, compared to 3.12M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 10.38% and a Short% of Float of 10.39%.
Earnings Estimates
The company has 4 analysts who recommend its stock at the moment. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0.12 and a low estimate of -$0.27, while EPS last year was -$0.43. The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.16 and low estimates of -$0.25.
Analysts are recommending an EPS of between -$0.94 and -$1.35 for the fiscal current year, implying an average EPS of -$1.08. EPS for the following year is -$0.87, with 4 analysts recommending between -$0.6 and -$1.15.
Revenue Estimates
A total of 3 analysts have provided revenue estimates for SLS’s current fiscal year. The highest revenue estimate was $13M, while the lowest revenue estimate was $13M, resulting in an average revenue estimate of $13M. In the same quarter a year ago, actual revenue was $1M, up 1,200.00% from the average estimate.
